Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Clodi, M; Abrahamian, H; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Hoppichler, F; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Fröhlich-Reiterer, E; Roden, M; Säly, C; Schernthaner, G; Sourij, H; Toplak, H; Wascher, TC; Weitgasser, R.
[Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S45-S53
Doi: 10.1007/s00508-016-0991-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Fröhlich-Reiterer Elke
- Sourij Harald
- Toplak Hermann
- Wascher Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hyperglycemia significantly contributes to micro- and macrovascular complications in patients with diabetes mellitus. While lifestyle interventions remain cornerstones of disease prevention and treatment, most patients with type 2 diabetes will eventually require pharmacotherapy for glycemic control. The definition of individual targets regarding optimal therapeutic efficacy and safety is of great importance. In this guideline we present the most current evidence-based best clinical practice data for healthcare professionals.
- Find related publications in this database (using NLM MeSH Indexing)
- Austria -
- Diabetes Mellitus, Type 2 - diagnosis
- Diabetes Mellitus, Type 2 - drug therapy
- Diabetes Mellitus, Type 2 - prevention & control
- Dose-Response Relationship, Drug -
- Drug Administration Schedule -
- Evidence-Based Medicine -
- Humans -
- Hyperglycemia - drug therapy
- Hyperglycemia - prevention & control
- Hypoglycemic Agents - administration & dosage
- Practice Guidelines as Topic -
- Treatment Outcome -
- Find related publications in this database (Keywords)
- Diabetes mellitus Type 2
- Therapy
- Glucose lowering